Macular Disease Foundation Australia logo

    Research news

    Research News

    MDFA awarded a total funding pool of more than $1 million in May 2021 to eight exciting researchers, bringing our total investment in research to $5.1m since 2011.

    Read more

    Most recent

    New gene therapy for AMD

    MDFA funded researcher, Dr Yvette Wooff is investigating cell particles called extracellular vesicles (EV), which could help develop novel gene therapies for dry AMD.

    10 years of MDFA Research Grants

    Celebrating the 10th anniversary of MDFA’s Research Grants Program, this free publication introduces you to the talented researchers your donations have funded since 2011.

    Improving real world evidence

    An MDFA Research Grant allowed Professor Mark Gillies to expand his Fight Retinal Blindness! project across the globe.

    Research grant helping AMD prevention

    MDFA funding allowed Prof Paul Mitchell to build upon his landmark Blue Mountains Eye Study.

    Macular research clinical trials

    The Centre for Eye Research Australia (CERA) teamed up with MDFA’s webinar series for the latest research updates on AMD, including how you can take part in vision research.

    Grant Family Fund bequest: Lasting legacy to ‘best mates’

    Faye Grant included MDFA in her Will. Her bequest is now funding vital, innovative research into macular disease through the Grant Family Fund.

    Million-dollar funding for macular disease research on World Sight Day

    MDFA will award $1 million in its latest round of research funding. It also announced a new stream of ‘blue sky’ grant funding.

    Scientists test potential drug developed in Australia

    A new chemical compound could become a future tool against retinal vascular disease. The finding is the result of a pre-clinical study, led by UNSW researchers.

    Lady with a coffee cup and mobile

    Vision Voice Summer 2019 out now

    The latest edition of our community newsletter, Vision Voice summer 2019, is about to hit letterboxes around Australia.